The companies say Merge will acquire all of the outstanding shares of AMICAS for an aggregate of $248 million. The Board of Directors of AMICAS has unanimously voted to terminate AMICAS’ previously announced agreement with an affiliate of Chicago-based Thoma Bravo, LLC and to enter into the Merge acquisition agreement.
According to the companies, AMICAS and Merge will become a global healthcare IT provider, bringing together an array of image and information management and related solutions. The combined company’s solution portfolio will range from comprehensive automation solutions for cardiology and radiology providers, enterprise content management solutions for IDN’s, to OEM solutions for health IT applications to trial, site and patient management solutions for pharmaceutical, biotechnology, medical device and contract research
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.